Drug recall · December 14, 2016
5% Lidocaine HCL and 7.5% Dextrose Injection recall
Why: Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01
- Lots / codes
Lot # 34-547-DK, 34-548-DK, Exp. 10/16, Lot # 39-372-DK, Exp. 03/17 Lot Number may be followed by numbers from 01 to 99
- Quantity
- 287,200 2 mL ampules
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- US and Puerto Rico
- Initiated
- June 29, 2016 · Voluntary: Firm initiated
- Classified
- December 6, 2016
- Reported
- December 14, 2016
- Ended
- November 20, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.